54 results
8-K
EX-1.1
TRML
Tourmaline Bio Inc
26 Jan 24
Other Events
4:12pm
at all times be effective and shall survive such termination.
Section 7. Reimbursement of Underwriters’ Expenses. If this Agreement is terminated
424B5
TRML
Tourmaline Bio Inc
26 Jan 24
Prospectus supplement for primary offering
4:08pm
product candidates, these products may become subject to unfavorable pricing regulations, reimbursement practices from third-party payors or healthcare … and reimbursement risks associated with doing business outside of the U.S.
Product liability lawsuits against us could cause us to incur substantial
424B5
TRML
Tourmaline Bio Inc
24 Jan 24
Prospectus supplement for primary offering
9:20pm
regulations, reimbursement practices from third-party payors or healthcare reform initiatives in the U.S. and abroad, which could harm our business.
We … to business, regulatory, political, operational, financial, pricing and reimbursement risks associated with doing business outside of the U.S.
Product
8-K
EX-99.2
rx1jvu8 0lc
24 Jan 24
Results of Operations and Financial Condition
5:10pm
8-K
EX-99.1
o8onqryzuwls0
24 Jan 24
Results of Operations and Financial Condition
5:10pm
8-K
EX-99.1
85ne2u7
8 Jan 24
Regulation FD Disclosure
9:19am
8-K
EX-10.1
u1ke563 j2n24
27 Oct 23
Departure of Directors or Certain Officers
5:17pm
425
pp4s6ass2nq8ox4m96
26 Sep 23
Business combination disclosure
8:24am
8-K
EX-99.1
2c797999v8wkt qy
26 Sep 23
Regulation FD Disclosure
8:21am
424B3
7g0 9tl5jw2bbz
15 Sep 23
Prospectus supplement
6:31am
S-4/A
751ou5m xqo6w
25 Aug 23
Registration of securities issued in business combination transactions (amended)
4:34pm
S-4
EX-10.4
6e2fq2e1
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
S-4
an67qgz5r 0igub
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
S-4
EX-10.15
k3bvr88 pw
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm